IMS26: Key readouts rock the multiple myeloma field amid shifting landscape
Data from AbbVie, J&J and BMS grabbed the attention of IMS 2026 attendees as the pharma titans battle for market share in multiple myeloma.
The post IMS26: Key readouts rock the multiple myeloma field amid shifting landscape appeared first on Clinical Trials Arena .